Ilsung IS

일성아이에스 · 003120

Health Care Pharmaceuticals · KOSPI

Small-cap

Market cap US$184M (₩253.9B)

Overview

Ilsung IS is a health-care company listed on KOSPI, South Korea's main stock exchange, operating in the pharmaceuticals or related health-care space.

The filing does not provide sufficient detail to describe its specific products, end-customers, or supply-chain position with confidence. The company is currently profitable, though its revenue has declined on a year-over-year basis.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$46.6M

▼ −6.8% YoY

Operating profit · FY2025

−US$4.5M

Loss narrowed

Net income · FY2025

US$844.8K

▼ −91.1% YoY

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$56.6M(₩78.1B)	US$50M(₩69B)	US$46.6M(₩64.3B)
Operating profit	−US$5.8M(−₩8B)	−US$6.9M(−₩9.5B)	−US$4.5M(−₩6.2B)
Net income	−US$15.2M(−₩20.9B)	US$9.5M(₩13.1B)	US$844.8K(₩1.2B)

Revenue

FY2023US$56.6M
FY2024US$50M
FY2025US$46.6M

Operating profit

FY2023−US$5.8M
FY2024−US$6.9M
FY2025−US$4.5M

Net income

FY2023−US$15.2M
FY2024US$9.5M
FY2025US$844.8K

Key ratios (FY2025)

ROE

0.3%

Debt/Eq

4.3%

Op. margin

-9.6%

Net margin

1.8%

Rev. YoY

▼ −6.8%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?